Skip to main content

Sotera Health Co

corporate_fare Company Profile

Sotera Health Co

SHC·NASDAQ·Industrial Applications And Services·CIK 0001822479

We are a leading global provider of mission-critical end-to-end sterilization solutions, lab testing, and advisory services for the healthcare industry. Our mission is Safeguarding Global Health®. We provide these services to ensure medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers in the United States and globally. In 2025, our customer base included over 40 of the top 50 medical device companies and nine of the top ten global pharmaceutical companies (based on revenue). Our services are crucial to our customers' manufacturing processes and supply chains, helping sterilized medical products reach healthcare practitioners and patients. Most of our services are required for customers to meet government regulations. We partner with customers in over 50 countries, aiming to ensure their products meet regulatory, safety, and effectiveness requirements. With our scientific and technological expertise, we contribute to the safety of millions of patients and healthcare practitioners worldwide. We operate 62 facilities globally and have over 3,000 employees focused on safety and quality. Our Sterilization Services business includes Sterigenics and Nordion. Sterigenics is a leading global provider of outsourced terminal sterilization and irradiation services, with over 90 years of experience. We offer a globally integrated platform for customers in the medical device, pharmaceutical, food safety, and advanced applications markets, with facilities located near manufacturing sites and distribution hubs. Terminal sterilization, an essential and often government-mandated final step, sterilizes a product in its final packaging before shipment. Products we sterilize include procedure kits and trays, implants, syringes, catheters, wound care products, medical protective barriers (including PPE), laboratory products, and pharmaceuticals.

Sotera Health Co (NASDAQ:SHC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 23 items for SHC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-03, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 17 rated 8 or above. Recent SEC coverage for SHC spans 144, 8-K, 424B7, 10-Q.

Recent high-impact activity:

  • Sotera Health Posts Solid Q3, Reaffirms 2026 Outlook as Leverage Falls to 2.9x
  • CEO Michael Petras Files to Sell $21.6M in Sotera Health Shares
  • Sotera Health Q2 2026: Revenue Climbs 9%, Net Income Hits $54M, Full-Year Outlook Raised
  • Sotera Health Raises FY 2026 Outlook After Strong Q2, Hits Leverage Target
  • Sotera Health reprices $1.42B term loan, reducing interest rate by 25 basis points

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.16B
Net Income
$77.95M
Diluted EPS
$0.27
Op. Cash Flow
$287.19M
Free Cash Flow
$149.18M
Gross Profit
$645.53M
Cash & Equivalents
$344.62M
Total Debt
$2.14B
Debt / Equity
3.53×
Net Margin
6.7%
Shares Outstanding
283.96M sh
Source: 10-K · filed 2026-02-24 · accession 0001822479-26-000015

Short Interest & Short Volume

7.53 days to cover

FINRA reported short interest of 16,439,623 shares in SHC as of the October 30, 2026 settlement, a 2.2% increase from the prior period — about 7.5 days to cover at its recent average daily volume. On November 20, 2026, 60.7% of SHC volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)16,439,623 shares as of October 30, 2026
Change vs prior period▲ 2.2%
Days to cover7.53 at avg daily volume of 2,182,981
Daily short volume (FINRA facilities)60.7% of 668,842 shares on November 20, 2026
5-day average short volume51.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with S →
$15.91
52-week range · as of 2026-08-17 $13.09 – $19.85
Market cap
$4.54B
Volume
1.7M (0.7× avg)
3-mo avg 2.5M
Live data · 2026-11-22 06:22 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SHC - Latest Insights

SHC
Nov 03, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $17.74
Real-time Price: $15.91 info
Change: -$1.83 (-10%) info
Market Cap: $4.544B info
SHC
Aug 17, 2026, 7:04 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $18.80
Real-time Price: $15.91 info
Change: -$2.89 (-15%) info
Market Cap: $4.544B info
SHC
Aug 06, 2026, 7:19 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $17.98
Real-time Price: $15.91 info
Change: -$2.07 (-12%) info
Market Cap: $4.544B info
SHC
Aug 06, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $17.98
Real-time Price: $15.91 info
Change: -$2.07 (-12%) info
Market Cap: $4.544B info
SHC
May 20, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $15.55
Real-time Price: $15.91 info
Change: +$0.360 (+2%) info
Market Cap: $4.544B info
SHC
May 13, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $15.48
Real-time Price: $15.91 info
Change: +$0.430 (+3%) info
Market Cap: $4.544B info
SHC
May 12, 2026, 4:42 PM EDT
Filing Type: 424B7
Importance Score:
9
Price at Filing: $15.61
Real-time Price: $15.91 info
Change: +$0.300 (+2%) info
Market Cap: $4.544B info
SHC
May 11, 2026, 5:07 PM EDT
Filing Type: 424B7
Importance Score:
9
Price at Filing: $15.22
Real-time Price: $15.91 info
Change: +$0.690 (+5%) info
Market Cap: $4.544B info
SHC
May 11, 2026, 4:33 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $15.10
Real-time Price: $15.91 info
Change: +$0.810 (+5%) info
Market Cap: $4.544B info
SHC
May 05, 2026, 4:19 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $15.33
Real-time Price: $15.91 info
Change: +$0.580 (+4%) info
Market Cap: $4.544B info
SHC
May 05, 2026, 4:15 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $15.33
Real-time Price: $15.91 info
Change: +$0.580 (+4%) info
Market Cap: $4.544B info
SHC
May 05, 2026, 7:13 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $16.00
Real-time Price: $15.91 info
Change: -$0.090 (-0.56%) info
Market Cap: $4.544B info
SHC
May 05, 2026, 7:03 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $16.00
Real-time Price: $15.91 info
Change: -$0.090 (-0.56%) info
Market Cap: $4.544B info
SHC
Apr 08, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $15.24
Real-time Price: $15.91 info
Change: +$0.670 (+4%) info
Market Cap: $4.544B info
SHC
Mar 10, 2026, 7:50 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $14.01
Real-time Price: $15.91 info
Change: +$1.90 (+14%) info
Market Cap: $4.544B info
SHC
Mar 10, 2026, 7:49 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $14.01
Real-time Price: $15.91 info
Change: +$1.90 (+14%) info
Market Cap: $4.544B info
SHC
Mar 10, 2026, 6:10 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $14.06
Real-time Price: $15.91 info
Change: +$1.85 (+13%) info
Market Cap: $4.544B info
SHC
Mar 05, 2026, 4:11 PM EST
Filing Type: 424B7
Importance Score:
8
Price at Filing: $15.28
Real-time Price: $15.91 info
Change: +$0.630 (+4%) info
Market Cap: $4.544B info
SHC
Mar 04, 2026, 5:20 PM EST
Filing Type: 424B7
Importance Score:
7
Price at Filing: $15.21
Real-time Price: $15.91 info
Change: +$0.700 (+5%) info
Market Cap: $4.544B info
SHC
Mar 04, 2026, 5:07 PM EST
Source: Reuters
Importance Score:
8
Price at Filing: $15.15
Real-time Price: $15.91 info
Change: +$0.760 (+5%) info
Market Cap: $4.544B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets